These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation. Kawano N; Okuda S; Yoshida S; Kugimiya H; Ito M; Horikawa N; Chosa N; Hisakata T; Fukudome T; Sakurai R; Yamashita K; Ueda A; Kanda Y Int J Hematol; 2011 Dec; 94(6):561-6. PubMed ID: 22057509 [TBL] [Abstract][Full Text] [Related]
3. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973 [TBL] [Abstract][Full Text] [Related]
5. A Case Report of Chronic Myelogenous Leukemia Presenting as Blastic Crisis with a T-Cell Acute Lymphoblastic Leukemia Phenotype: Awareness of a Rare Entity. Efstathopoulou M; Zoi K; Siakantaris MP; Koumbi D; Zannou A; Triantafyllou EF; Tsourouflis G; Lakiotaki E; Vassilakopoulos TP; Angelopoulou MK Acta Haematol; 2023; 146(6):531-539. PubMed ID: 37557081 [TBL] [Abstract][Full Text] [Related]
6. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Steinberg M Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072 [TBL] [Abstract][Full Text] [Related]
7. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia. Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674 [TBL] [Abstract][Full Text] [Related]
8. Philadelphia chromosome negative acute lymphoblastic leukemia preceding Philadelphia positive chronic myelogenous leukemia. Hörnsten P; Nordenson I; Wahlin A Cancer Genet Cytogenet; 1989 Jun; 39(2):147-52. PubMed ID: 2752368 [TBL] [Abstract][Full Text] [Related]
9. Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia. Al-Shehri A; Al-Seraihy A; Owaidah TM; Belgaumi AF Hematol Oncol Stem Cell Ther; 2010; 3(1):42-6. PubMed ID: 20231813 [TBL] [Abstract][Full Text] [Related]
10. Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate. Matsuda M; Morita Y; Shimada T; Miyatake J; Hirase C; Tanaka M; Tatsumi Y; Maeda Y; Kanamaru A Int J Hematol; 2005 May; 81(4):307-9. PubMed ID: 15914360 [TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Kantarjian HM; Cortes J; O'Brien S; Giles FJ; Albitar M; Rios MB; Shan J; Faderl S; Garcia-Manero G; Thomas DA; Resta D; Talpaz M Blood; 2002 May; 99(10):3547-53. PubMed ID: 11986206 [TBL] [Abstract][Full Text] [Related]
12. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597 [TBL] [Abstract][Full Text] [Related]
13. Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence. Roman J; Andres P; Jimenez MA; Torres A Br J Haematol; 1994 Jul; 87(3):624-6. PubMed ID: 7993807 [TBL] [Abstract][Full Text] [Related]
14. [Research advance on molecular genetics of CML blast crisis]. Zhu HQ; Zhang S; Liu XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935 [TBL] [Abstract][Full Text] [Related]
15. Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report. Dong Q; Darwish T; Howard M; Shetty S; Wang Y; Xiu Y; Gallogly M; Zhao C J Int Med Res; 2024 Feb; 52(2):3000605231156757. PubMed ID: 38422030 [TBL] [Abstract][Full Text] [Related]
16. Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Ninomiya S; Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Moriwaki H Int J Hematol; 2011 Jun; 93(6):806-810. PubMed ID: 21523337 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias. Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136 [TBL] [Abstract][Full Text] [Related]